Back

Value of CHA2DS2-VASc score and safe contrast volume for early detection of contrast induced nephropathy after percutaneous coronary intervention

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Percutaneous Coronary Intervention (PCI) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Wael Khalil

Zagazig University Hospitals, Zagazig (Egypt)

133 More presentations in this session

Presentation thumbnail
Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.
Doctor M. Verdoia (Biella, IT)
Abstract Slides
Presentation thumbnail
Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age
Professor F. Abdullayev (Baku, AZ)
Abstract Slides
Presentation thumbnail
Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR
Assistant Professor V. Veulemans (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study
Doctor I. Lozano Martinez-Luengas (Gijon, ES)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes following percutaneous coronary intervention in a tertiary cardiac centre in the UK
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement
thumbnail
Congress Presentation
Percutaneous coronary intervention and risk of major adverse cardiovascular events in patients with coronary artery ectasia and acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources